Trial · NCT03363633
Perforator Vein Injection for Symptomatic Venous Disease
NCT03363633, Not applicable, Terminated, Ellen Dillavou; results first posted 2018-02-23
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Perforator Vein Injection for Symptomatic Venous Disease. Trials, record NCT03363633. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03363633
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Perforator Vein Injection for Symptomatic Venous Disease
- NCT number
- NCT03363633
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 12 participants, actual
- Lead sponsor
- Ellen Dillavou
- Conditions
- Venous Disease
- Interventions
- sodium tetradecyl sulfate, Compression
- First posted
- 2017-12-06
- Last updated
- 2018-02-23
- Results first posted
- 2018-02-23
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Ulcer Healing | 12 months | Change in wound size, reported in square centimeters |
| Secondary | Venous Clinical Severity Score (VCSS) | 12 months | The VCSS includes nine criteria of chronic venous disease, each graded from 0 to 3 (0=absent, 1=mild, 2=moderate, 3=severe). Up to three points may be added for differences in background conservative therapy (compression and elevation). The scores are then added, with a maximum score of 30. |
| Secondary | Injection Complications | 12 months | Number of participants experiencing venous thromboses from injections |
| Secondary | Compliance With Compression Therapy | 12 months | Number of participants who use compression therapy |
| Secondary | Ulcer Recurrence | 12 months | Number of participants with ulcers that reopen after initial closure |
Source ClinicalTrials.gov
Outcomes5
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Ulcer Healing | 12 months | The Responsible Party is no longer at University of Pittsburgh and has confirmed that the study data were lost. The only information available is the study was terminated for recruitment difficulty following enrollment of 12 participants overall, with no breakdown per study arm (source: final report submitted to the IRB). | ||
| SECONDARY | Venous Clinical Severity Score (VCSS) | 12 months | The Responsible Party is no longer at University of Pittsburgh and has confirmed that the study data were lost. The only information available is the study was terminated for recruitment difficulty following enrollment of 12 participants overall, with no breakdown per study arm (source: final report submitted to the IRB). | ||
| SECONDARY | Injection Complications | 12 months | The Responsible Party is no longer at University of Pittsburgh and has confirmed that the study data were lost. The only information available is the study was terminated for recruitment difficulty following enrollment of 12 participants overall, with no breakdown per study arm (source: final report submitted to the IRB). | ||
| SECONDARY | Compliance With Compression Therapy | 12 months | The Responsible Party is no longer at University of Pittsburgh and has confirmed that the study data were lost. The only information available is the study was terminated for recruitment difficulty following enrollment of 12 participants overall, with no breakdown per study arm (source: final report submitted to the IRB). | ||
| SECONDARY | Ulcer Recurrence | 12 months | The Responsible Party is no longer at University of Pittsburgh and has confirmed that the study data were lost. The only information available is the study was terminated for recruitment difficulty following enrollment of 12 participants overall, with no breakdown per study arm (source: final report submitted to the IRB). |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | All Arms | 12 | |
| Overall Study | COMPLETED | All Arms | 0 | |
| Overall Study | NOT COMPLETED | All Arms | 12 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | All Arms | ||
| Total, other adverse events | All Arms | 0 | 12 |
| Total, serious adverse events | All Arms | 0 | 12 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 37497816 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03363633
GET https://conductscience.org/api/trials/v1/NCT03363633/registered